Structure

Physi-Chem Properties

Molecular Weight:  256.11
Volume:  276.095
LogP:  2.884
LogD:  3.118
LogS:  -3.316
# Rotatable Bonds:  4
TPSA:  49.69
# H-Bond Aceptor:  3
# H-Bond Donor:  2
# Rings:  2
# Heavy Atoms:  3

MedChem Properties

QED Drug-Likeness Score:  0.825
Synthetic Accessibility Score:  2.241
Fsp3:  0.125
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Accepted
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  2
PAINS Alert:  1

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.734
MDCK Permeability:  1.8635739252204075e-05
Pgp-inhibitor:  0.005
Pgp-substrate:  0.003
Human Intestinal Absorption (HIA):  0.006
20% Bioavailability (F20%):  0.896
30% Bioavailability (F30%):  0.738

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.298
Plasma Protein Binding (PPB):  99.16886901855469%
Volume Distribution (VD):  0.615
Pgp-substrate:  1.2358537912368774%

ADMET: Metabolism

CYP1A2-inhibitor:  0.98
CYP1A2-substrate:  0.83
CYP2C19-inhibitor:  0.87
CYP2C19-substrate:  0.156
CYP2C9-inhibitor:  0.732
CYP2C9-substrate:  0.923
CYP2D6-inhibitor:  0.836
CYP2D6-substrate:  0.874
CYP3A4-inhibitor:  0.512
CYP3A4-substrate:  0.336

ADMET: Excretion

Clearance (CL):  10.817
Half-life (T1/2):  0.876

ADMET: Toxicity

hERG Blockers:  0.061
Human Hepatotoxicity (H-HT):  0.033
Drug-inuced Liver Injury (DILI):  0.152
AMES Toxicity:  0.159
Rat Oral Acute Toxicity:  0.042
Maximum Recommended Daily Dose:  0.02
Skin Sensitization:  0.942
Carcinogencity:  0.728
Eye Corrosion:  0.013
Eye Irritation:  0.939
Respiratory Toxicity:  0.235

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC60885

Natural Product ID:  NPC60885
Common Name*:   Hydroxyobustyrene
IUPAC Name:   3-methoxy-4-[(E)-3-phenylprop-2-enyl]benzene-1,2-diol
Synonyms:   Hydroxyobustyrene
Standard InCHIKey:  WGXMQVRYJCAUFL-VMPITWQZSA-N
Standard InCHI:  InChI=1S/C16H16O3/c1-19-16-13(10-11-14(17)15(16)18)9-5-8-12-6-3-2-4-7-12/h2-8,10-11,17-18H,9H2,1H3/b8-5+
SMILES:  COc1c(C/C=C/c2ccccc2)ccc(c1O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL243672
PubChem CID:   11777169
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0003467] Linear 1,3-diarylpropanoids
        • [CHEMONTID:0003496] Cinnamylphenols

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO14114 Dalbergia parviflora Species Fabaceae Eukaryota heartwood n.a. n.a. PMID[19928832]
NPO18117 Dalbergia odorifera Species Fabaceae Eukaryota heartwood n.a. n.a. PMID[23743282]
NPO18117 Dalbergia odorifera Species Fabaceae Eukaryota n.a. n.a. n.a. PMID[9525107]
NPO18117 Dalbergia odorifera Species Fabaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO22420 Lignum dalbergiae odoriferae rosewood n.a. n.a. n.a. n.a. n.a. n.a. Database[TCMID]
NPO18117 Dalbergia odorifera Species Fabaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO18117 Dalbergia odorifera Species Fabaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO18117 Dalbergia odorifera Species Fabaceae Eukaryota n.a. n.a. n.a. Database[TM-MC]
NPO18117 Dalbergia odorifera Species Fabaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO14114 Dalbergia parviflora Species Fabaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT80 Cell Line Raji Homo sapiens Survival = 60.0 % PMID[570441]
NPT80 Cell Line Raji Homo sapiens Survival > 80.0 % PMID[570441]
NPT396 Cell Line T47D Homo sapiens Activity > 100.0 uM PMID[570442]
NPT83 Cell Line MCF7 Homo sapiens Activity > 100.0 uM PMID[570442]
NPT396 Cell Line T47D Homo sapiens Activity = 5.1 uM PMID[570442]
NPT164 Organism Human herpesvirus 4 Human herpesvirus 4 Inhibition = 10.2 % PMID[570441]
NPT164 Organism Human herpesvirus 4 Human herpesvirus 4 Inhibition = 41.3 % PMID[570441]
NPT164 Organism Human herpesvirus 4 Human herpesvirus 4 Inhibition = 71.0 % PMID[570441]
NPT164 Organism Human herpesvirus 4 Human herpesvirus 4 Inhibition = 100.0 % PMID[570441]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC60885 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC234400
0.9916 High Similarity NPC44748
0.9916 High Similarity NPC28730
0.9916 High Similarity NPC78974
0.9916 High Similarity NPC214406
0.9916 High Similarity NPC223136
0.9916 High Similarity NPC18924
0.9916 High Similarity NPC103823
0.9833 High Similarity NPC169474
0.9833 High Similarity NPC159968
0.9833 High Similarity NPC74817
0.9833 High Similarity NPC124452
0.9833 High Similarity NPC236791
0.9833 High Similarity NPC293054
0.9833 High Similarity NPC282000
0.9833 High Similarity NPC82679
0.9833 High Similarity NPC246620
0.9833 High Similarity NPC324112
0.9832 High Similarity NPC82483
0.9832 High Similarity NPC265483
0.9832 High Similarity NPC299584
0.9672 High Similarity NPC58164
0.9672 High Similarity NPC10225
0.9667 High Similarity NPC221077
0.9667 High Similarity NPC251855
0.9667 High Similarity NPC57490
0.9667 High Similarity NPC208950
0.9667 High Similarity NPC233410
0.9667 High Similarity NPC116907
0.9667 High Similarity NPC117214
0.9667 High Similarity NPC203133
0.9667 High Similarity NPC193544
0.9667 High Similarity NPC475169
0.9667 High Similarity NPC298757
0.9667 High Similarity NPC472093
0.9667 High Similarity NPC105925
0.9667 High Similarity NPC17943
0.9664 High Similarity NPC95168
0.9593 High Similarity NPC234488
0.9593 High Similarity NPC299221
0.9593 High Similarity NPC311680
0.9593 High Similarity NPC126836
0.9593 High Similarity NPC51840
0.959 High Similarity NPC154866
0.959 High Similarity NPC28765
0.958 High Similarity NPC262253
0.958 High Similarity NPC41562
0.958 High Similarity NPC71579
0.958 High Similarity NPC473411
0.9516 High Similarity NPC474356
0.9516 High Similarity NPC12275
0.9516 High Similarity NPC45715
0.9512 High Similarity NPC212015
0.9508 High Similarity NPC252131
0.9508 High Similarity NPC266555
0.9508 High Similarity NPC210355
0.9508 High Similarity NPC236760
0.9508 High Similarity NPC127587
0.95 High Similarity NPC282496
0.95 High Similarity NPC197757
0.95 High Similarity NPC136319
0.95 High Similarity NPC121115
0.95 High Similarity NPC228922
0.95 High Similarity NPC233526
0.9496 High Similarity NPC75713
0.944 High Similarity NPC6451
0.9431 High Similarity NPC98631
0.9431 High Similarity NPC470213
0.9431 High Similarity NPC206615
0.9431 High Similarity NPC266691
0.9431 High Similarity NPC186843
0.9426 High Similarity NPC223953
0.9426 High Similarity NPC76451
0.9421 High Similarity NPC206487
0.9421 High Similarity NPC122792
0.9421 High Similarity NPC5796
0.9421 High Similarity NPC228972
0.9412 High Similarity NPC166759
0.9407 High Similarity NPC20674
0.9365 High Similarity NPC471391
0.9365 High Similarity NPC475840
0.9365 High Similarity NPC471390
0.9365 High Similarity NPC229442
0.9365 High Similarity NPC168059
0.9365 High Similarity NPC32778
0.936 High Similarity NPC232275
0.9355 High Similarity NPC190144
0.9355 High Similarity NPC476968
0.9355 High Similarity NPC170844
0.9328 High Similarity NPC474565
0.9328 High Similarity NPC232084
0.9328 High Similarity NPC10932
0.9328 High Similarity NPC247364
0.9328 High Similarity NPC61516
0.9291 High Similarity NPC317380
0.9286 High Similarity NPC86655
0.9286 High Similarity NPC202762
0.9286 High Similarity NPC127624
0.928 High Similarity NPC91291
0.928 High Similarity NPC192687
0.928 High Similarity NPC214860
0.928 High Similarity NPC224157
0.928 High Similarity NPC472338
0.9262 High Similarity NPC183446
0.9244 High Similarity NPC226629
0.9237 High Similarity NPC259638
0.9219 High Similarity NPC108198
0.9219 High Similarity NPC474206
0.9219 High Similarity NPC158142
0.9219 High Similarity NPC472337
0.9219 High Similarity NPC94750
0.9219 High Similarity NPC69029
0.9219 High Similarity NPC200557
0.9219 High Similarity NPC121812
0.9219 High Similarity NPC313081
0.9219 High Similarity NPC112246
0.9219 High Similarity NPC10314
0.9219 High Similarity NPC256262
0.9219 High Similarity NPC294884
0.9219 High Similarity NPC112939
0.9219 High Similarity NPC470356
0.9213 High Similarity NPC36661
0.9206 High Similarity NPC472597
0.9206 High Similarity NPC474017
0.9206 High Similarity NPC470096
0.9206 High Similarity NPC15543
0.9206 High Similarity NPC470095
0.92 High Similarity NPC469963
0.92 High Similarity NPC469951
0.92 High Similarity NPC45824
0.9194 High Similarity NPC242032
0.9194 High Similarity NPC470699
0.918 High Similarity NPC84086
0.9174 High Similarity NPC285289
0.9174 High Similarity NPC49341
0.9153 High Similarity NPC193067
0.9147 High Similarity NPC143139
0.9147 High Similarity NPC16435
0.9147 High Similarity NPC248727
0.9147 High Similarity NPC265433
0.9147 High Similarity NPC202846
0.9147 High Similarity NPC227503
0.9147 High Similarity NPC230734
0.9147 High Similarity NPC474639
0.9147 High Similarity NPC270456
0.9147 High Similarity NPC306441
0.9147 High Similarity NPC472334
0.9147 High Similarity NPC162659
0.9147 High Similarity NPC472336
0.9141 High Similarity NPC7515
0.9141 High Similarity NPC289258
0.9141 High Similarity NPC276026
0.9141 High Similarity NPC206737
0.9141 High Similarity NPC56764
0.9141 High Similarity NPC209199
0.9141 High Similarity NPC106215
0.9141 High Similarity NPC125649
0.9141 High Similarity NPC469659
0.9141 High Similarity NPC555
0.9141 High Similarity NPC188378
0.9134 High Similarity NPC160991
0.9134 High Similarity NPC16208
0.9134 High Similarity NPC184447
0.9134 High Similarity NPC7903
0.9134 High Similarity NPC201587
0.9134 High Similarity NPC35932
0.9134 High Similarity NPC253105
0.9113 High Similarity NPC181361
0.9113 High Similarity NPC112596
0.9098 High Similarity NPC474864
0.9098 High Similarity NPC135414
0.9098 High Similarity NPC246967
0.9091 High Similarity NPC102639
0.9083 High Similarity NPC475961
0.9083 High Similarity NPC254625
0.9077 High Similarity NPC6262
0.9077 High Similarity NPC107551
0.9077 High Similarity NPC276490
0.9077 High Similarity NPC211549
0.9077 High Similarity NPC474282
0.9077 High Similarity NPC272157
0.9077 High Similarity NPC326797
0.9077 High Similarity NPC102904
0.9077 High Similarity NPC90615
0.9077 High Similarity NPC176051
0.9077 High Similarity NPC73535
0.9077 High Similarity NPC103976
0.9077 High Similarity NPC56329
0.9077 High Similarity NPC242715
0.9077 High Similarity NPC201145
0.9077 High Similarity NPC25111
0.9076 High Similarity NPC33270
0.9076 High Similarity NPC69261
0.9076 High Similarity NPC474933
0.907 High Similarity NPC180602
0.907 High Similarity NPC260898
0.907 High Similarity NPC241241
0.907 High Similarity NPC214853
0.907 High Similarity NPC234333
0.907 High Similarity NPC61946

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC60885 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9355 High Similarity NPD3027 Phase 3
0.8968 High Similarity NPD1529 Clinical (unspecified phase)
0.8889 High Similarity NPD1530 Clinical (unspecified phase)
0.8837 High Similarity NPD1613 Approved
0.8837 High Similarity NPD1612 Clinical (unspecified phase)
0.874 High Similarity NPD3018 Phase 2
0.8729 High Similarity NPD228 Approved
0.8571 High Similarity NPD2982 Phase 2
0.8571 High Similarity NPD2983 Phase 2
0.8492 Intermediate Similarity NPD2981 Phase 2
0.8387 Intermediate Similarity NPD1548 Phase 1
0.8281 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.8279 Intermediate Similarity NPD5283 Phase 1
0.8268 Intermediate Similarity NPD1610 Phase 2
0.8244 Intermediate Similarity NPD4908 Phase 1
0.812 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.8082 Intermediate Similarity NPD2801 Approved
0.8045 Intermediate Similarity NPD4625 Phase 3
0.8043 Intermediate Similarity NPD3540 Phase 1
0.8014 Intermediate Similarity NPD1934 Approved
0.8 Intermediate Similarity NPD4749 Approved
0.8 Intermediate Similarity NPD1558 Phase 1
0.7973 Intermediate Similarity NPD3882 Suspended
0.7971 Intermediate Similarity NPD3539 Phase 1
0.7951 Intermediate Similarity NPD3021 Approved
0.7951 Intermediate Similarity NPD3022 Approved
0.7881 Intermediate Similarity NPD1242 Phase 1
0.7846 Intermediate Similarity NPD422 Phase 1
0.7838 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7832 Intermediate Similarity NPD1511 Approved
0.782 Intermediate Similarity NPD6917 Clinical (unspecified phase)
0.7815 Intermediate Similarity NPD940 Approved
0.7815 Intermediate Similarity NPD846 Approved
0.7761 Intermediate Similarity NPD2861 Phase 2
0.774 Intermediate Similarity NPD1653 Approved
0.7737 Intermediate Similarity NPD3620 Phase 2
0.7737 Intermediate Similarity NPD3619 Clinical (unspecified phase)
0.7734 Intermediate Similarity NPD5536 Phase 2
0.7727 Intermediate Similarity NPD3600 Clinical (unspecified phase)
0.7724 Intermediate Similarity NPD1512 Approved
0.7721 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7721 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.7708 Intermediate Similarity NPD4357 Discontinued
0.7664 Intermediate Similarity NPD2674 Phase 3
0.7661 Intermediate Similarity NPD4750 Phase 3
0.7632 Intermediate Similarity NPD6234 Discontinued
0.7616 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7615 Intermediate Similarity NPD1357 Approved
0.7613 Intermediate Similarity NPD6166 Phase 2
0.7613 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7613 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7609 Intermediate Similarity NPD4060 Phase 1
0.7609 Intermediate Similarity NPD1240 Approved
0.7581 Intermediate Similarity NPD2684 Approved
0.7578 Intermediate Similarity NPD6671 Approved
0.7576 Intermediate Similarity NPD3705 Approved
0.7569 Intermediate Similarity NPD5307 Clinical (unspecified phase)
0.7552 Intermediate Similarity NPD3060 Approved
0.755 Intermediate Similarity NPD3817 Phase 2
0.7533 Intermediate Similarity NPD37 Approved
0.7517 Intermediate Similarity NPD4675 Approved
0.7517 Intermediate Similarity NPD7124 Phase 2
0.7517 Intermediate Similarity NPD4678 Approved
0.75 Intermediate Similarity NPD290 Approved
0.75 Intermediate Similarity NPD1607 Approved
0.7484 Intermediate Similarity NPD6232 Discontinued
0.7468 Intermediate Similarity NPD7054 Approved
0.7464 Intermediate Similarity NPD3144 Approved
0.7464 Intermediate Similarity NPD3145 Approved
0.7458 Intermediate Similarity NPD2934 Approved
0.7458 Intermediate Similarity NPD9296 Approved
0.7458 Intermediate Similarity NPD2933 Approved
0.7451 Intermediate Similarity NPD7975 Clinical (unspecified phase)
0.745 Intermediate Similarity NPD4005 Discontinued
0.7448 Intermediate Similarity NPD2219 Phase 1
0.7447 Intermediate Similarity NPD6111 Discontinued
0.7444 Intermediate Similarity NPD1091 Approved
0.7431 Intermediate Similarity NPD5177 Phase 3
0.7421 Intermediate Similarity NPD7074 Phase 3
0.7421 Intermediate Similarity NPD7472 Approved
0.7419 Intermediate Similarity NPD7199 Phase 2
0.7413 Intermediate Similarity NPD2029 Clinical (unspecified phase)
0.7413 Intermediate Similarity NPD7266 Discontinued
0.7407 Intermediate Similarity NPD2922 Phase 1
0.7405 Intermediate Similarity NPD3818 Discontinued
0.7395 Intermediate Similarity NPD2859 Approved
0.7395 Intermediate Similarity NPD2860 Approved
0.7394 Intermediate Similarity NPD1510 Phase 2
0.7386 Intermediate Similarity NPD4966 Approved
0.7386 Intermediate Similarity NPD4965 Approved
0.7386 Intermediate Similarity NPD4967 Phase 2
0.7372 Intermediate Similarity NPD9494 Approved
0.7365 Intermediate Similarity NPD1940 Clinical (unspecified phase)
0.7357 Intermediate Similarity NPD943 Approved
0.7355 Intermediate Similarity NPD3020 Approved
0.7347 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7344 Intermediate Similarity NPD7843 Approved
0.7343 Intermediate Similarity NPD6099 Approved
0.7343 Intermediate Similarity NPD6100 Approved
0.7342 Intermediate Similarity NPD7473 Discontinued
0.7338 Intermediate Similarity NPD4055 Discovery
0.7325 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7319 Intermediate Similarity NPD5752 Clinical (unspecified phase)
0.7315 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.731 Intermediate Similarity NPD5698 Clinical (unspecified phase)
0.731 Intermediate Similarity NPD4236 Phase 3
0.731 Intermediate Similarity NPD4237 Approved
0.7308 Intermediate Similarity NPD7157 Approved
0.7305 Intermediate Similarity NPD230 Phase 1
0.7299 Intermediate Similarity NPD6584 Phase 3
0.7297 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7297 Intermediate Similarity NPD7447 Phase 1
0.7296 Intermediate Similarity NPD7228 Approved
0.7293 Intermediate Similarity NPD4626 Approved
0.7285 Intermediate Similarity NPD4380 Phase 2
0.728 Intermediate Similarity NPD968 Approved
0.7279 Intermediate Similarity NPD8651 Approved
0.7267 Intermediate Similarity NPD6797 Phase 2
0.7255 Intermediate Similarity NPD1465 Phase 2
0.7244 Intermediate Similarity NPD5451 Approved
0.7241 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7234 Intermediate Similarity NPD2238 Phase 2
0.723 Intermediate Similarity NPD7213 Phase 3
0.723 Intermediate Similarity NPD6799 Approved
0.723 Intermediate Similarity NPD7212 Phase 2
0.7222 Intermediate Similarity NPD2935 Discontinued
0.7222 Intermediate Similarity NPD7251 Discontinued
0.7214 Intermediate Similarity NPD5109 Approved
0.7214 Intermediate Similarity NPD5718 Phase 2
0.7214 Intermediate Similarity NPD5111 Phase 2
0.7214 Intermediate Similarity NPD5110 Phase 2
0.7195 Intermediate Similarity NPD8054 Approved
0.7195 Intermediate Similarity NPD8053 Approved
0.7192 Intermediate Similarity NPD1652 Phase 2
0.7192 Intermediate Similarity NPD6674 Discontinued
0.7181 Intermediate Similarity NPD1424 Approved
0.7181 Intermediate Similarity NPD4123 Phase 3
0.7178 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7178 Intermediate Similarity NPD7808 Phase 3
0.7176 Intermediate Similarity NPD709 Approved
0.7172 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7172 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.7164 Intermediate Similarity NPD5846 Approved
0.7164 Intermediate Similarity NPD6516 Phase 2
0.7161 Intermediate Similarity NPD6788 Approved
0.7153 Intermediate Similarity NPD6028 Clinical (unspecified phase)
0.7153 Intermediate Similarity NPD6029 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD2978 Approved
0.7143 Intermediate Similarity NPD3892 Phase 2
0.7143 Intermediate Similarity NPD7095 Approved
0.7143 Intermediate Similarity NPD3750 Approved
0.7143 Intermediate Similarity NPD2977 Approved
0.7143 Intermediate Similarity NPD5844 Phase 1
0.7133 Intermediate Similarity NPD4097 Suspended
0.7133 Intermediate Similarity NPD5261 Clinical (unspecified phase)
0.7132 Intermediate Similarity NPD2230 Approved
0.7132 Intermediate Similarity NPD2232 Approved
0.7132 Intermediate Similarity NPD2233 Approved
0.7124 Intermediate Similarity NPD5090 Approved
0.7124 Intermediate Similarity NPD5089 Approved
0.7123 Intermediate Similarity NPD1549 Phase 2
0.7115 Intermediate Similarity NPD7075 Discontinued
0.7107 Intermediate Similarity NPD844 Approved
0.7105 Intermediate Similarity NPD6055 Clinical (unspecified phase)
0.7105 Intermediate Similarity NPD7261 Clinical (unspecified phase)
0.7103 Intermediate Similarity NPD2796 Approved
0.7097 Intermediate Similarity NPD6374 Clinical (unspecified phase)
0.7095 Intermediate Similarity NPD2677 Approved
0.7095 Intermediate Similarity NPD5241 Discontinued
0.7095 Intermediate Similarity NPD6190 Approved
0.7092 Intermediate Similarity NPD6798 Discontinued
0.7083 Intermediate Similarity NPD4536 Approved
0.7083 Intermediate Similarity NPD4538 Approved
0.7083 Intermediate Similarity NPD4537 Clinical (unspecified phase)
0.708 Intermediate Similarity NPD6583 Phase 3
0.708 Intermediate Similarity NPD6582 Phase 2
0.7075 Intermediate Similarity NPD4162 Approved
0.7063 Intermediate Similarity NPD6355 Discontinued
0.7063 Intermediate Similarity NPD5124 Phase 1
0.7063 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7055 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7037 Intermediate Similarity NPD2668 Approved
0.7037 Intermediate Similarity NPD2667 Approved
0.7037 Intermediate Similarity NPD1778 Approved
0.7032 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7029 Intermediate Similarity NPD6696 Suspended
0.7027 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7027 Intermediate Similarity NPD6331 Phase 2
0.7025 Intermediate Similarity NPD5494 Approved
0.7007 Intermediate Similarity NPD1608 Approved
0.7006 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD5297 Approved
0.6987 Remote Similarity NPD2560 Approved
0.6987 Remote Similarity NPD2563 Approved
0.6986 Remote Similarity NPD1551 Phase 2
0.6985 Remote Similarity NPD3496 Discontinued
0.6985 Remote Similarity NPD3847 Discontinued
0.6978 Remote Similarity NPD3053 Approved
0.6978 Remote Similarity NPD2797 Approved
0.6978 Remote Similarity NPD3055 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data